Receptor Tyrosine Kinase inhibitors - Globe Thesis

Keyword [Receptor Tyrosine Kinase inhibitors] Result: 1 - 20 \| Page: 1 of 3
1.	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (gefitinib) In China With Advanced Non-small Cell Lung Cancer Patients In The Efficacy And Safety Studies And Clinical Efficacy Predictors
2.	Synthesis 3-Substituted Indolin-2-ones: A Novel Class Of Receptor Tyrosine Kinase Inhibitors
3.	The Effects Of Combined Administration Of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors And Cytotoxic Drugs In Different Tumor Cell Lines
4.	Design Vascular Endothelial Growth Factor Receptor-2 Receptor Tyrosine Kinase Inhibitors
5.	Ptk787 The Synthesis Study And Benzo Triazine Compound Design And Synthesis
6.	Cloning And Expression Of Human Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Screening Model To Build
7.	The Important Role Of T790M And EMT In Prognosis Of Chemotherapy In NSCLC With Acquired Resistance Of EGFR-TKI
8.	Design,Synthesis And Biological Activity Evaluation Of Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
9.	The Anti-Cancer Activities Of1122-37, A Novel Derivative Of Sorafenib, And Its Mechanism
10.	Recurrence Patterns In Patients With Advanced Non-small Cell Lung Cancer After Treated With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
11.	RCTs Tyrosine Kinase Inhibitor Medical Treatment Related To The Rash Of Epidermal Growth Factor Receptor
12.	Individualized Therapy Of Advanced Non-small Cell Lung Cancer With Acquired Resistance To Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
13.	Docetaxel Versus EGFR-TKIs As Second-line Treatment Of Patients With Advanced Non-small-cell-lung Cancer
14.	Study On The Structure Activity Relationship Of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
15.	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors In The Treatment Of Central Nerve System Metastases From Non-Small Cell Lung Cancer
16.	The Function Of FBW7 In The Development Of Acquired Resistance To Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors In Non-small Cell Lung Cancer
17.	Study Of The Sensitivity To EGFR-TKI Modulated By P53 On Triple-negative Breast Cancer Cells
18.	The Role Of Cancer Stem Cells In EMT-induced Acquired Resistance To EGFR-TKIs In NSCLC Cells
19.	Efficacy Of EGFR-Tyrosine Kinase Inhibitors And Clinical Pathologic Features Analysis Between Exon 19 Deletion And L858R Mutation With Advanced Non-Small Cell Lung Cancer
20.	The Role Of Autophagy In Modulation Of Resistance To Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors In Non-small Cell Lung Cancer
<<First <Prev Next> Last>> Jump to